Patent ID: 6384042
Filing Date: 2002-05-07
Classification: A61K,A61P

Abstract:
A method for systemic treatment of an inflammatory rheumatic or rheumatoid disease or condition, other than crystal induced arthritis and other than living pathogen induced inflammatory diseases, as long as the living pathogen is still present comprising administering a therapeutically effective amount of a 5-HT3 receptor antagonist or a pharmaceutically acceptable salt thereof to a subject in need thereof, wherein the disease to be treated is selected from the group consisting of:(1) chronic polyarthritis, (2) paraneoplastic syndrome or tumor-induced inflammatory diseases, (3) turbid effusions, (4) collagenosis, (5) postinfectious arthritis, (6) seronegative spondylarthritis, (7) vasculitis, (8) sarcoidosis, and (9) arthrosis.